Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.04B | 2.72B | 1.92B | 2.90B | 3.37B |
Gross Profit | 54.73M | 161.91M | 114.71M | 243.63M | 628.10M |
EBITDA | -60.25M | 131.05M | -7.27M | 200.34M | 603.68M |
Net Income | -165.55M | 10.99M | -347.35M | 41.81M | 331.67M |
Balance Sheet | |||||
Total Assets | 6.25B | 6.07B | 6.27B | 6.94B | 6.46B |
Cash, Cash Equivalents and Short-Term Investments | 213.72M | 252.49M | 222.98M | 248.75M | 183.92M |
Total Debt | 1.36B | 1.05B | 904.95M | 799.98M | 581.41M |
Total Liabilities | 5.39B | 5.06B | 5.27B | 5.59B | 5.14B |
Stockholders Equity | 854.50M | 1.01B | 1.00B | 1.35B | 1.32B |
Cash Flow | |||||
Free Cash Flow | -2.50M | -30.64M | -166.04M | -155.83M | 218.35M |
Operating Cash Flow | 36.01M | -28.94M | -165.79M | -151.39M | 232.94M |
Investing Cash Flow | -63.11M | 16.34M | 47.23M | -104.07M | -34.42M |
Financing Cash Flow | 48.20M | -26.40M | 95.28M | 315.00M | -345.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
53 Neutral | $1.18B | 3.34 | -0.11% | 7.12% | -1.52% | -126.00% | |
48 Neutral | HK$269.48M | 5.92 | 1.93% | ― | -4.98% | ― | |
47 Neutral | €1.17B | ― | -20.46% | 5.04% | -29.12% | -1450.50% | |
44 Neutral | HK$175.18M | ― | -10.46% | ― | -7.60% | 41.01% | |
43 Neutral | HK$193.15M | ― | -17.73% | ― | -25.98% | -1588.59% | |
41 Neutral | HK$75.17M | ― | -307.85% | ― | -17.03% | -141.21% |
China Tianbao Group Development Company Limited announced that all resolutions proposed at its Annual General Meeting on June 26, 2025, were approved by shareholders. The resolutions included the adoption of financial statements, re-election of directors, authorization of director remuneration, appointment of auditors, and mandates for share issuance and buy-back. This unanimous approval reflects strong shareholder support and could enhance the company’s operational flexibility and governance.
China Tianbao Group Development Company Limited has announced its upcoming annual general meeting scheduled for June 26, 2025, in Hebei Province, China. The meeting will address several key resolutions, including the adoption of the 2024 financial statements, re-election of directors, and the appointment of auditors. Additionally, the company seeks approval for a general mandate to issue new shares, which could impact its capital structure and market activities.
China Tianbao Group Development Company Limited has announced a change in its auditor, with Ernst & Young retiring after the upcoming annual general meeting due to a disagreement over remuneration for the next financial year. The company plans to appoint CCTH CPA Limited as the new auditor, citing cost-effectiveness and enhanced corporate governance as reasons for the change, which is expected to benefit the company and its shareholders.
China Tianbao Group Development Company Limited has announced the official operation of the Tianbao Jingbei Health City as of May 28, 2025. The project, which includes a hospital, nursing center, and elderly care community, aligns with the national strategy for the development of the elderly service economy. It covers a site area of approximately 200,000 square meters and is designed to provide extensive healthcare and elderly care facilities, including 350 medical treatment beds and 8,800 beds for elderly healthcare. The project is expected to enhance the company’s positioning in the healthcare sector and contribute to its revenue generation in 2025.
China Tianbao Group Development Company Limited has announced a postponement of its Annual General Meeting originally scheduled for May 22, 2025, now rescheduled to a date on or before June 30, 2025, due to an adjustment in work arrangements. Consequently, the book closure period to determine shareholders entitled to attend the meeting will also be revised, with details to be announced later, impacting shareholders’ ability to transfer shares during the new closure period.